Search
Search Results
##search.searchResults.foundPlural##
-
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
1946PDF: 1816HTML: 327 -
THE ROLE OF SLC22A4 IN ACUTE MYELOID LEUKEMIA
389PDF: 200HTML: 70 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
893PDF: 444HTML: 63 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3664PDF: 1411HTML: 459Figures . Eliassian: 203 -
-
AUTOIMMUNE CYTOPENIAS IN CHRONIC LYMPHOCYTIC LEUKEMIA, FACTS AND MYTHS
2110PDF: 1158HTML: 3680 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4329PDF: 1863HTML: 17709 -
TP53-MUTATED MYELODYSPLASIA AND ACUTE MYELOID LEUKEMIA TP53 in MDS and AML
1980PDF: 1596HTML: 345 -
IMMUNOLOGICAL DEREGULATION IN HODGKIN’S DISEASE
2162PDF: 925HTML: 1868 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2252PDF: 937HTML: 7606Untitled: 253Fig2: 162Fig3: 142Fig4: 161 -
UPDATE ON CYTOMEGALOVIRUS INFECTION MANAGEMENT IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS A Consensus Document of the Spanish Group for Hematopoietic Transplantation and Cell Therapy (GETH-TC)
3741Suppl. Files: 1045PDF: 1017Html: 107 -
EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS EBV-RELATED LYMPHOPROLIFERATIVE DISEASES
3992PDF: 1534HTML: 834 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2544PDF: 1043HTML: 98 -
-
DETECTION OF OCCULT GLOMERULAR DYSFUNCTION IN GLUCOSE SIX PHOSPHATE DEHYDROGENASE DEFICIENCY ANEMIA
3648PDF: 1192HTML: 1691Untitled: 143 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1181PDF: 699HTML: 289 -
HIV INFECTION, ANTIRETROVIRAL THERAPY AND CARDIOVASCULAR RISK
1764PDF: 778HTML: 3580 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3763PDF: 1410HTML: 8485 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3559PDF: 1368HTML: 168 -
CURRENT KNOWLEDGE ON HIV-ASSOCIATED PLASMABLASTIC LYMPHOMA
2516PDF: 1568HTML: 2334Table1: 172 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1327PDF: 656HTML: 1067Untitled: 164Untitled: 129Untitled: 113Untitled: 136Untitled: 142 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
7672PDF: 3972HTML: 7289 -
TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2510PDF: 837HTML: 17443Fig1 Caligaris: 143Fig.2 Caliga: 176 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
3737PDF: 3068HTML: 182 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
1866PDF: 768HTML: 204 -
THE ROLE OF INFECTION IN THE PATHOGENESIS OF VASO-OCCLUSIVE CRISIS IN PATIENTS WITH SICKLE CELL DISEASE.
5046PDF: 1288HTML: 2724Cover letter: 173 -
-
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
985PDF: 930HTML: 300 -
THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C VIRUS INFECTION
3969PDF: 1868HTML: 1746 -
Guest Editor: Pellegrino Musto BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA: APPROPRIATE SELECTION OF PATIENTS AND SEQUENCING BISPECIFIC ANTIBODIES AND CAR T IN MULTIPLE MYELOMA
1437PDF: 1126HTML: 171







